Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fassari, C."'
Autor:
Oddone, F., Kirwan, J., Lopez-Lopez, F., Zimina, M., Fassari, C., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Erichev, V., Adbulaeva, E., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Rodriguez-Agirretxe, I., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Nita, A., Smith, M., Moosavi, A., King, A. J. W., Kinsella, M.
Publikováno v:
The VISIONARY Study Group 2022, ' Correction to : Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment (Advances in Therapy, (2022), 39, 8, (3501-3521), 10.1007/s12325-022-02166-6) ', Advances in Therapy, vol. 39, no. 8, pp. 3522-3523 . https://doi.org/10.1007/s12325-022-02210-5
The authors would like to acknowledge missing data for all prior latanoprost users as a whole. The following sentence has been added to the manuscript (page 8, first paragraph): Mean (SD) reduction from baseline at Month 6 for users of all latanopros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::812340febaa5f0771a874cb09eeec33e
https://hdl.handle.net/11391/1538074
https://hdl.handle.net/11391/1538074
Autor:
Oddone, F., Kirwan, J., Lopez-Lopez, F., Zimina, M., Fassari, C., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Erichev, V., Adbulaeva, E., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Rodriguez-Agirretxe, I., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Nita, A., Smith, M., Moosavi, A., King, A. J. W., Kinsella, M.
Publikováno v:
The VISIONARY Study Group 2022, ' Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension : Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment ', Advances in Therapy, vol. 39, no. 8, pp. 3501-3521 . https://doi.org/10.1007/s12325-022-02166-6
Introduction: The VISIONARY study demonstrated statistically significant intraocular pressure (IOP) reductions with the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol 0.5% (PF tafluprost/timolol FC) in open-angle glaucoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6249f0b9c7c70a793a68dd3fa6775d8e
http://hdl.handle.net/11391/1530993
http://hdl.handle.net/11391/1530993
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oddone F; Glaucoma Unit, IRCSS-Fondazione Bietti, Rome, Italy. oddonef@gmail.com., Kirwan J; Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK., Lopez-Lopez F; Instituto Oftalmologico Gomez-Ulla, Calle Maruxa Mallo 3 Santiago de Compostela, Galicia, Spain., Zimina M; LLC Vzglyad, Leningradskaya, Chita, Russia., Fassari C; Santen SA, Geneva, Switzerland., Holló G; Tutkimusz Ltd, Solymár, Hungary.; Eye Center, Prima Medica Health Centers, Budapest, Hungary.
Publikováno v:
Advances in therapy [Adv Ther] 2022 Aug; Vol. 39 (8), pp. 3501-3521. Date of Electronic Publication: 2022 May 07.
Autor:
Oddone F; Glaucoma Unit, IRCSS-Fondazione Bietti, Rome, Italy. oddonef@gmail.com., Kirwan J; Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK., Lopez-Lopez F; Instituto Oftalmologico Gomez-Ulla, Calle Maruxa Mallo 3 Santiago de Compostela, Galicia, Spain., Zimina M; LLC Vzglyad, Leningradskaya, Chita, Russia., Fassari C; Santen SA, Geneva, Switzerland., Holló G; Tutkimusz Ltd, Solymár, Hungary.; Eye Center, Prima Medica Health Centers, Budapest, Hungary.
Publikováno v:
Advances in therapy [Adv Ther] 2022 Aug; Vol. 39 (8), pp. 3522-3523.